Does SITAGLIPTIN Cause Benign prostatic hyperplasia? 64 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 64 reports of Benign prostatic hyperplasia have been filed in association with SITAGLIPTIN (JANUVIA). This represents 0.3% of all adverse event reports for SITAGLIPTIN.
64
Reports of Benign prostatic hyperplasia with SITAGLIPTIN
0.3%
of all SITAGLIPTIN reports
48
Deaths
56
Hospitalizations
How Dangerous Is Benign prostatic hyperplasia From SITAGLIPTIN?
Of the 64 reports, 48 (75.0%) resulted in death, 56 (87.5%) required hospitalization, and 18 (28.1%) were considered life-threatening.
Is Benign prostatic hyperplasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SITAGLIPTIN. However, 64 reports have been filed with the FAERS database.
What Other Side Effects Does SITAGLIPTIN Cause?
Blood glucose increased (1,427)
Pancreatic carcinoma (1,142)
Product dose omission issue (1,125)
Drug ineffective (1,057)
No adverse event (994)
Nausea (936)
Pancreatitis (922)
Diabetes mellitus inadequate control (744)
Diarrhoea (712)
Hypoglycaemia (674)
What Other Drugs Cause Benign prostatic hyperplasia?
TADALAFIL (596)
TAMSULOSIN (304)
FINASTERIDE (266)
PANTOPRAZOLE (261)
PREDNISONE (257)
ALBUTEROL (254)
ASPIRIN (243)
TIOTROPIUM (235)
RAMIPRIL (193)
AMLODIPINE (179)
Which SITAGLIPTIN Alternatives Have Lower Benign prostatic hyperplasia Risk?
SITAGLIPTIN vs SOAP
SITAGLIPTIN vs SODIUM
SITAGLIPTIN vs SODIUM BICARBONATE
SITAGLIPTIN vs SODIUM BICARBONATE\SODIUM
SITAGLIPTIN vs SODIUM BORATE